Baudax Bio, Inc.
Index- P/E0.67 EPS (ttm)4.50 Insider Own0.30% Shs Outstand11.84M Perf Week-4.44%
Market Cap1.50M Forward P/E- EPS next Y-4.42 Insider Trans400.00% Shs Float0.50M Perf Month30.87%
Income-22.50M PEG- EPS next Q-9.76 Inst Own7.30% Short Float / Ratio11.69% / 0.03 Perf Quarter-63.47%
Sales1.40M P/S1.07 EPS this Y92.60% Inst Trans12.31% Short Interest0.06M Perf Half Y-89.29%
Book/sh-1.65 P/B- EPS next Y97.70% ROA-56.20% Target Price24.00 Perf Year-98.71%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.55 - 306.46 Perf YTD-5.35%
Dividend- P/FCF- EPS past 5Y- ROI-87.60% 52W High-99.02% Beta-
Dividend %- Quick Ratio0.30 Sales past 5Y- Gross Margin- 52W Low94.19% ATR0.74
Employees80 Current Ratio0.50 Sales Q/Q-33.30% Oper. Margin- RSI (14)45.52 Volatility24.12% 19.79%
OptionableNo Debt/Eq- EPS Q/Q64.90% Profit Margin- Rel Volume0.18 Prev Close3.02
ShortableYes LT Debt/Eq- EarningsNov 08 AMC Payout0.00% Avg Volume2.10M Price3.01
Recom3.00 SMA20-9.73% SMA50-19.97% SMA200-86.11% Volume380,105 Change-0.33%
May-15-20Initiated JMP Securities Mkt Outperform $13
Jan-24-23 08:00AM
Dec-08-22 08:00AM
Dec-06-22 04:11PM
Dec-02-22 02:46PM
Nov-30-22 04:50PM
04:09PM Loading…
Nov-08-22 04:09PM
Sep-19-22 04:05PM
Sep-08-22 04:05PM
Sep-01-22 02:56PM
Aug-30-22 10:49AM
Aug-29-22 10:04PM
Aug-22-22 08:00AM
Aug-11-22 07:00AM
Jun-01-22 08:00AM
May-18-22 08:00AM
07:00PM Loading…
May-17-22 07:00PM
May-05-22 05:00PM
May-04-22 05:00PM
May-02-22 04:05PM
Apr-13-22 08:00AM
Apr-11-22 12:00PM
Apr-05-22 10:46AM
Mar-16-22 08:00AM
Mar-10-22 07:00AM
Mar-08-22 08:00AM
Mar-07-22 08:00AM
Mar-02-22 07:00AM
Feb-24-22 11:23PM
Feb-15-22 08:29PM
12:29PM Loading…
Jan-07-22 12:29PM
Jan-04-22 07:00AM
Dec-31-21 04:05PM
Dec-28-21 08:00AM
Nov-15-21 07:00AM
Nov-11-21 07:00AM
Nov-04-21 07:00AM
Oct-28-21 07:00AM
Oct-05-21 07:00AM
Oct-01-21 04:17PM
Sep-16-21 07:00AM
Sep-07-21 07:00AM
Aug-25-21 08:54AM
Aug-05-21 07:00AM
Jul-30-21 04:05PM
Jul-29-21 07:00AM
Jul-01-21 07:00AM
Jun-30-21 07:00AM
Jun-18-21 04:05PM
Jun-10-21 07:00AM
Jun-08-21 07:00AM
May-31-21 10:56PM
May-28-21 04:05PM
May-27-21 07:00AM
May-17-21 07:00AM
May-13-21 07:00AM
May-12-21 09:02AM
May-11-21 04:05PM
May-05-21 07:00AM
Apr-29-21 07:00AM
Apr-26-21 07:00AM
Apr-12-21 08:32AM
Apr-01-21 07:00AM
Mar-10-21 07:00AM
Mar-08-21 07:00AM
Mar-02-21 07:00AM
Feb-17-21 12:32AM
Feb-16-21 07:00AM
Feb-10-21 08:05AM
Feb-08-21 03:24PM
Feb-01-21 10:05PM
Jan-21-21 09:29AM
Jan-06-21 07:00AM
Dec-17-20 07:00AM
Dec-08-20 08:40AM
Dec-07-20 05:17PM
Nov-30-20 04:05PM
Nov-23-20 08:00AM
Nov-20-20 07:00AM
Nov-19-20 07:00AM
Nov-11-20 05:30AM
Nov-09-20 07:15AM
Nov-02-20 07:05AM
Oct-20-20 07:00AM
Oct-02-20 04:05PM
Sep-18-20 07:35AM
Sep-01-20 03:30PM
Aug-25-20 04:05PM
Aug-20-20 05:57PM
Aug-17-20 12:28PM
Aug-10-20 07:15AM
Aug-06-20 04:05PM
Jul-30-20 04:05PM
Jul-20-20 07:00AM
Jul-05-20 02:53PM
Jul-03-20 03:25PM
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENWOOD GERALDINEPresident and CEODec 15Buy2.551,2003,0572,427Dec 19 08:09 AM